Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'EARLY PARKINSONS-DISEASE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 66 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zafonte, RD; Lexell, J; Cullen, N
      Possible applications for dopaminergic agents following traumatic brain injury: Part 2

      JOURNAL OF HEAD TRAUMA REHABILITATION
    2. Saletu, M; Anderer, P; Saletu, B; Hauer, C; Mandl, M; Semler, B; Saletu-Zyhlarz, G
      Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    3. Maratos, EC; Jackson, MJ; Pearce, RKB; Jenner, P
      Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

      MOVEMENT DISORDERS
    4. Ahlskog, JE; Muenter, MD
      Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature

      MOVEMENT DISORDERS
    5. Zesiewicz, TA; Hauser, RA
      Phenomenology and treatment of tremor disorders

      NEUROLOGIC CLINICS
    6. Booij, J; Reneman, L; Lavalaye, J; Knol, RJJ; de Bruin, K; Speelman, JD; Janssen, AGM
      Dopamine transporter imaging as an in vivo marker of dopaminergic neurons

      DRUGS OF THE FUTURE
    7. Tuite, P; Ebbitt, B
      Dopamine agonists

      SEMINARS IN NEUROLOGY
    8. de la Fuente-Fernandez, R; Lim, AS; Sossi, V; Holden, JE; Calne, DB; Ruth, TJ; Stoessl, AJ
      Apomorphine-induced changes in synaptic dopamine levels: Positron emissiontomography evidence for presynaptic inhibition

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    9. Lee, AC; Harris, JP; Atkinson, EA; Fowler, MS
      Disruption of estimation of body-scaled aperture width in Hemiparkinson's disease

      NEUROPSYCHOLOGIA
    10. Lees, AJ; Katzenschlager, R; Head, J; Ben-Shlomo, Y
      Ten-year follow-up of three different initial treatments in de-novo PD - Arandomized trial

      NEUROLOGY
    11. Morrison, CE; Borod, JC; Brin, MF; Raskin, SA; Germano, IM; Weisz, DJ; Olanow, CW
      A program for neuropsychological investigation of deep brain stimulation (PNIDBS) in movement disorder patients: Development, feasibility, and preliminary data

      NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY
    12. Mach, RH; Nader, MA; Ehrenkaufer, RL; Gage, HD; Childers, SR; Hodges, LM; Hodges, MM; Davies, HML
      Fluorine-18-labeled tropane analogs for PET imaging studies of the dopamine transporter

      SYNAPSE
    13. Hauser, RA; Gauger, L; Anderson, WM; Zesiewicz, TA
      Pramipexole-induced somnolence and episodes of daytime sleep

      MOVEMENT DISORDERS
    14. Kaye, CM; Nicholls, B
      Clinical pharmacokinetics of ropinirole

      CLINICAL PHARMACOKINETICS
    15. Araki, T; Tanji, H; Fujihara, K; Kato, H; Imai, Y; Mizugaki, M; Itoyama, Y
      Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats

      JOURNAL OF NEURAL TRANSMISSION
    16. Middleton, FA; Strick, PL
      Basal ganglia output and cognition: Evidence from anatomical, behavioral, and clinical studies

      BRAIN AND COGNITION
    17. Lam, YWF
      Clinical pharmacology of dopamine agonists

      PHARMACOTHERAPY
    18. Middleton, FA; Strick, PL
      Basal ganglia and cerebellar loops: motor and cognitive circuits

      BRAIN RESEARCH REVIEWS
    19. Bergstrom, KA; Harkonen, R; Kairemo, K; Karonen, SL; Knuuti, J; Kuikka, JT; Lamberg, BA; Lansimies, E; Liewendahl, K; Nikkinen, P; Rekonen, A; Savolainen, S; Vanninen, E; Vauramo, E; Wegelius, U
      The development of nuclear medicine in Finland: a review on the occasion of the 40th anniversary of the Finnish Society of Nuclear Medicine

      CLINICAL PHYSIOLOGY
    20. Rascol, O; Montastruc, JL
      Role of dopaminergic agonists

      REVUE NEUROLOGIQUE
    21. Kemppainen, N; Ruottinen, H; Nagren, K; Rinne, JO
      PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD

      NEUROLOGY
    22. Reavill, C; Boyfield, I; Coldwell, M; Nelson, P
      Comparative pharmacological study of ropinirole (SKF-101468) and its metabolites in rats

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    23. Stoll, AL; Renshaw, PF; Yurgelun-Todd, DA; Cohen, BM
      Neuroimaging in bipolar disorder: What have we learned?

      BIOLOGICAL PSYCHIATRY
    24. Iacoboni, M; Baron, JC; Frackowiak, RSJ; Mazziotta, JC; Lenzi, GL
      Emission tomography contribution to clinical neurology

      CLINICAL NEUROPHYSIOLOGY
    25. Moresco, RM; Loc'h, C; Ottaviani, M; Guibert, B; Leviel, V; Maziere, M; Fazio, F; Maziere, B
      Effects of dopamine on the in vivo binding of dopamine D-2 receptor radioligands in rat striatum

      NUCLEAR MEDICINE AND BIOLOGY
    26. Rinne, JO
      Drug development for neurodegenerative diseases: role of PET

      ANNALS OF MEDICINE
    27. de la Fuente-Fernandez, R
      Drug-induced motor complications in dopa-responsive dystonia: Implicationsfor the pathogenesis of dyskinesias and motor fluctuations

      CLINICAL NEUROPHARMACOLOGY
    28. Hobson, DE; Pourcher, E; Martin, WRW
      Ropinirole and pramipexole, the new agonists

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    29. Wang, GJ; Volkow, ND; Fowler, JS; Logan, J; Pappas, NR; Wong, CT; Hitzemann, RJ; Netusil, N
      Reproducibility of repeated measures of endogenous dopamine competition with [C-11]raclopride in the human brain in response to methylphenidate

      JOURNAL OF NUCLEAR MEDICINE
    30. Le Bras, C; Pillon, B; Damier, P; Dubois, B
      At which steps of spatial working memory processing do striatofrontal circuits intervene in humans?

      NEUROPSYCHOLOGIA
    31. Barone, P; Bravi, D; Bermejo-Pareja, F; Marconi, R; Kulisevsky, J; Malagu, S; Weiser, R; Rost, N
      Pergolide monotherapy in the treatment of early PD - A randomized, controlled study

      NEUROLOGY
    32. Schneider, JS; Tinker, JP; Van Velson, M; Menzaghi, F; Lloyd, GK
      Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    33. Henry, B; Crossman, AR; Brotchie, JM
      Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat

      EXPERIMENTAL NEUROLOGY
    34. Perachon, S; Schwartz, JC; Sokoloff, P
      Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D-1, D-2 and D-3 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    35. Coldwell, MC; Boyfield, I; Brown, T; Hagen, JJ; Middlemiss, DN
      Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D-2(long), D-3 and D-4.4 receptors expressed in Chinese hamster ovary cells

      BRITISH JOURNAL OF PHARMACOLOGY
    36. Tanji, H; Araki, T; Nagasawa, H; Itoyama, Y
      Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP

      BRAIN RESEARCH
    37. Verhoeff, NPLG
      Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders

      PSYCHOPHARMACOLOGY
    38. Ilgin, N
      Functional imaging of neurotransmitter systems in movement disorders

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    39. BROOKS DJ
      POSITRON-EMISSION-TOMOGRAPHY STUDIES IN MOVEMENT-DISORDERS

      Neurosurgery clinics of North America
    40. POEWE WH; RASCOL O; BROOKS DJ; BRUNT ER; KORCZYN AD; STOCCHI F
      ROPINIROLE IN THE TREATMENT OF EARLY PARKINSONS-DISEASE - A 6-MONTH INTERIM-REPORT OF A 5-YEAR LEVODOPA-CONTROLLED STUDY

      Movement disorders
    41. KORCZYN AD; BROOKS DJ; BRUNT ER; POEWE WH; RASCOL O; STOCCHI F
      ROPINIROLE VERSUS BROMOCRIPTINE IN THE TREATMENT OF EARLY PARKINSONS-DISEASE - A 6-MONTH INTERIM-REPORT OF A 3-YEAR STUDY

      Movement disorders
    42. SCHNEIDER JS; VANVELSON M; MENZAGHI F; LLOYD GK
      EFFECTS OF THE NICOTINIC ACETYLCHOLINE-RECEPTOR AGONIST SIB-1508Y ON OBJECT RETRIEVAL PERFORMANCE IN MPTP-TREATED MONKEYS - COMPARISON WITHLEVODOPA TREATMENT

      Annals of neurology
    43. TANILA H; BJORKLUND M; RIEKKINEN P
      COGNITIVE CHANGES IN MICE FOLLOWING MODERATE MPTP EXPOSURE

      Brain research bulletin
    44. KISHORE A; NYGAARD TG; DELAFUENTEFERNANDEZ R; NAINI AB; SCHULZER M; MAK E; RUTH TJ; CALNE DB; SNOW BJ; STOESSL AJ
      STRIATAL D2 RECEPTORS IN SYMPTOMATIC AND ASYMPTOMATIC CARRIERS OF DOPA-RESPONSIVE DYSTONIA MEASURED WITH [C-11] RACLOPRIDE AND POSITRON-EMISSION-TOMOGRAPHY

      Neurology
    45. BROWN LL; SCHNEIDER JS; LIDSKY TI
      SENSORY AND COGNITIVE FUNCTIONS OF THE BASAL GANGLIA

      Current opinion in neurobiology
    46. WALKER Z; COSTA DC; JANSSEN AG; WALKER RWH; LIVINGSTONE G; KATONA CLE
      DEMENTIA WITH LEWY BODIES - A STUDY OF POSTSYNAPTIC DOPAMINERGIC RECEPTORS WITH I-123 IODOBENZAMIDE SINGLE-PHOTON EMISSION TOMOGRAPHY

      European journal of nuclear medicine
    47. MOERLEIN SM; PERLMUTTER JS; MARKHAM J; WELCH MJ
      IN-VIVO KINETICS OF [F-18] (N-METHYL)BENPERIDOL - A NOVEL PET TRACER FOR ASSESSMENT OF DOPAMINERGIC D2-LIKE RECEPTOR-BINDING

      Journal of cerebral blood flow and metabolism
    48. SAVAGE CR
      NEUROPSYCHOLOGY OF SUBCORTICAL DEMENTIAS

      The Psychiatric clinics of North America
    49. BENTUEFERRER D; MENARD G; ALLAIN H
      MONOAMINE-OXIDASE-B INHIBITORS - CURRENT STATUS AND FUTURE POTENTIAL

      CNS DRUGS
    50. SEEGAL RF
      EPIDEMIOLOGIC AND LABORATORY EVIDENCE OF PCB-INDUCED NEUROTOXICITY

      Critical reviews in toxicology
    51. KNOWLTON BJ; MANGELS JA; SQUIRE LR
      A NEOSTRIATAL HABIT LEARNING-SYSTEM IN HUMANS

      Science
    52. NAGASAWA H; TANJI H; ITOYAMA Y; SAITO H; KIMURA I; FUJIWARA T; IWATA R; ITOH M; IDO T
      BRAIN 6-[F-18]FLUORODOPA METABOLISM IN EARLY AND LATE-ONSET OF PARKINSONS-DISEASE STUDIED BY POSITRON EMISSION TOMOGRAPHY

      Journal of the neurological sciences
    53. FUKUYAMA H; KAWAMURA J; AKIGUCHI I; KIMURA J; IMAI T
      BROMOCRIPTINE THERAPY IN EARLY-STAGE PARKINSONS-DISEASE

      European neurology
    54. DUPONT E; ANDERSEN A; BOAS J; BOISEN E; BORGMANN R; HELGETVEIT AC; KJAER MO; KRISTENSEN TN; MIKKELSEN B; PAKKENBERG H; PRESTHUS J; STIEN R; WORMPETERSEN J; BUCH D
      SUSTAINED-RELEASE MADOPAR HBS(R) COMPARED WITH STANDARD MADOPAR(R) INTHE LONG-TERM TREATMENT OF DE-NOVO PARKINSONIAN-PATIENTS

      Acta neurologica Scandinavica
    55. MACH RH; EHRENKAUFER RLE; GREENBERG JH; SHAO LX; MORTON TE; EVORA PH; NOWAK PA; LUEDTKE RR; COHEN D; REIVICH M
      PET IMAGING STUDIES OF DOPAMINE D-2 RECEPTORS - COMPARISON OF [F-18] N-METHYLSPIPERONE AND THE BENZAMIDE ANALOGS [F-18]MABN AND [F-18] MBP IN BABOON BRAIN

      Synapse
    56. MOERLEIN SM; PERLMUTTER JS; WELCH MJ
      USP STANDARDS FOR RACLOPRIDE C-11 INJECTION

      Pharmacopeial forum
    57. BUCK A; WESTERA G; SUTTER M; ALBANI C; KUNG HF; VONSCHULTHESS GK
      IODINE-223-IBF SPECT EVALUATION OF EXTRAPYRAMIDAL DISEASES

      The Journal of nuclear medicine
    58. SAWLE GV
      IMAGING THE HEAD - FUNCTIONAL IMAGING

      Journal of Neurology, Neurosurgery and Psychiatry
    59. AMIN F; SEEMAN TE; MOHS RC; DAVIDSON M; KNOTT P; BERKMAN LF; ALBERT M; BLAZER D
      PLASMA HOMOVANILLIC-ACID AND PERFORMANCE ON MOTOR AND COGNITIVE TASKSIN COMMUNITY-DWELLING ELDERLY - MACARTHUR STUDIES OF SUCCESSFUL AGING

      Neuropsychopharmacology
    60. MUTHANE UB; SWAMY HS; SATISHCHANDRA P; SUBHASH MN; RAO S; SUBBAKRISHNA D
      EARLY-ONSET PARKINSONS-DISEASE - ARE JUVENILE-ONSET AND YOUNG-ONSET DIFFERENT

      Movement disorders
    61. SAUBERLICH HE
      PHARMACOLOGY OF VITAMIN-C

      Annual review of nutrition
    62. ROELTGEN DP; SCHNEIDER JS
      TASK PERSISTENCE AND LEARNING-ABILITY IN NORMAL AND CHRONIC LOW-DOSE MPTP-TREATED MONKEYS

      Behavioural brain research
    63. SCHNEIDER JS; SUN ZQ; ROELTGEN DP
      EFFECTS OF DOPAMINE AGONISTS ON DELAYED-RESPONSE PERFORMANCE IN CHRONIC LOW-DOSE MPTP-TREATED MONKEYS

      Pharmacology, biochemistry and behavior
    64. MUTHANE UB; SATISHCHANDRA P; SUBHASH MN
      VISUAL AND AUDITORY-EVOKED POTENTIALS IN EARLY-ONSET PARKINSONS-DISEASE AND THEIR RELATIONSHIP TO CEREBROSPINAL-FLUID MONOAMINE METABOLITES

      Movement disorders
    65. ISHIKAWA A; MIYATAKE T
      EFFECTS OF SMOKING IN PATIENTS WITH EARLY-ONSET PARKINSONS-DISEASE

      Journal of the neurological sciences
    66. RANDOLPH C; HYDE TM; GOLD JM; GOLDBERG TE; WEINBERGER DR
      TOURETTES-SYNDROME IN MONOZYGOTIC TWINS - RELATIONSHIP OF TIC SEVERITY TO NEUROPSYCHOLOGICAL FUNCTION

      Archives of neurology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 17/02/20 alle ore 08:21:27